학술논문

Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
Document Type
Journal
Source
PEDIATRIC BLOOD & CANCER; MAR 10 2021, pe28946 8p.
Subject
Language
English
ISSN
15455017